Drug recall D-0689-2026
Product
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
Reason for recall
Lack of Assurance of Sterility
Lots and codes
Lot #: 1239521, 1237454, Exp. Date 10/2027
Recall details
- Recalling firm
- Chiesi USA, Inc., Cary, NC
- Quantity
- 44280 vials
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- July 6, 2026
Related products
- Cleviprex – drug information
- NDC 10122-611 Cleviprex · Clevidipine .5 mg/mL · Chiesi USA, Inc.
- NDC 10122-610 Cleviprex · Clevidipine .5 mg/mL · Chiesi USA, Inc.